Osteonecrosis Clinical Trials

Find Osteonecrosis Clinical Trials Near You

Medication Related Osteonecrosis of the Jaws (MRONJ) in a Cohort of Patients Treated by Antiresorptive Drugs: a Cohort Prospective Study

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Observational
SUMMARY

The objective of this prospective observational study is to investigate the incidence of Medication Related Osteonecrosis of the Jaws (MRONJ) in patients receiving antiresorptive drugs for oncohematologic reasons during a 5-year follow-up. Secondary objectives are to compare the different antiresorptive drugs in relation to the incidence of MRONJ and to identify any systemic as well as local risk factors.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients with specific prescription to initiate therapy with antiresorptive drugs

Locations
Other Locations
Italy
Cosimo Rupe
RECRUITING
Roma
Contact Information
Primary
Carlo Lajolo, Prof.
carlo.lajolo@unicatt.it
3356078354
Time Frame
Start Date: 2021-01-01
Estimated Completion Date: 2028-01-01
Participants
Target number of participants: 126
Treatments
Antiresorptive Drugs
Patients treated by means of Antiresorptive drugs due to either bone metastasis or metabolic diseases
Related Therapeutic Areas
Sponsors
Leads: Catholic University of the Sacred Heart

This content was sourced from clinicaltrials.gov